Integra Lifesciences Holdings (IART) Cash & Equivalents Growth (3y) (2012 - 2026)
Powered by 
Analysis
Integra Lifesciences Holdings (IART) Cash & Equivalents Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -13.31% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -7.03% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 8.09% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 34.27% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 8.16% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 40.74% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 27.03% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -2.57% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 32.23% |
| 10 | Integra Lifesciences Holdings | 1.25 Bn | 977.26 Mn | 219.74 Mn | -11.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.49% |
| Mar 31, 2026 | -8.33% |
| Dec 31, 2025 | -19.86% |
| Sep 30, 2025 | -23.17% |
| Jun 30, 2025 | -21.31% |
| Mar 31, 2025 | -16.25% |
| Dec 31, 2024 | -21.71% |
| Sep 30, 2024 | -22.94% |
| Jun 30, 2024 | -18.49% |
| Mar 31, 2024 | 13.11% |
| Dec 31, 2023 | -16.23% |
| Sep 30, 2023 | -11.60% |
| Jun 30, 2023 | -5.03% |
| Mar 31, 2023 | -4.93% |
| Dec 31, 2022 | 31.92% |
| Sep 30, 2022 | 35.02% |
| Jun 30, 2022 | 36.43% |
| Mar 31, 2022 | 37.38% |
| Dec 31, 2021 | 54.64% |
| Sep 30, 2021 | 31.67% |